TIL
Instil Bio, Inc.
+0.04 (+0.56%)7.22USD4.5K成交股數49.0M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 270K | 669K | 3.5M | 9.1M | 6.7M | 5.4M | 562K | 2.9M | 7.3M | 2.0M | 8.5M | 8.5M |
| 銷售管理費用 | 5.1M | 5.3M | 6.1M | 5.9M | 6.2M | 9.1M | 10.7M | 10.7M | 12.4M | 10.9M | 11.9M | 11.5M |
| 營業利益 | −5.6M-76% | −7.0M-77% | −9.6M-60% | −15.0M+6% | −23.4M-2% | −30.6M+135% | −23.6M-65% | −14.1M-33% | −24.0M | −13.0M | −66.7M | −21.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −4.3M-80% | −4.2M-85% | −8.2M-64% | −13.6M-9% | −21.4M-12% | −28.2M+118% | −23.0M-66% | −14.9M-20% | −24.3M | −12.9M | −67.4M | −18.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.63-81% | -0.62-86% | -1.13-68% | -2.01-12% | -3.24-13% | -4.32+117% | -3.54-66% | -2.29-20% | -3.74 | -1.99 | -10.37 | -2.87 |
| 稀釋股數 | 6.8M | 6.8M | 6.7M | 6.8M | 6.6M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M | 6.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.5M | 5.0M | 6.6M | 5.8M | 7.7M | 15.4M | 6.7M | 6.8M | 5.5M | 9.2M | 9.1M | 21.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 198M | 200M | 204M | 212M | 231M | 237M | 273M | 294M | 306M | 326M | 340M | 408M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 90.3M | 89.7M | 89.7M | 91.3M | 99.3M | 92.5M | 96.2M | 99.3M | 100M | 99.8M | 106M | 112M |
| 股東權益 | 107M | 111M | 114M | 120M | 132M | 145M | 176M | 195M | 206M | 226M | 234M | 297M |
| 負債比 | 45.7% | 44.8% | 44.1% | 43.1% | 43.0% | 39.0% | 35.3% | 33.7% | 32.8% | 30.6% | 31.2% | 27.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.3M-68% | – | – | – | −4.2M | – | – | −14.4M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −14.4M | – | – | – |
| 折舊攤銷 | – | 12K | – | – | – | 498K | – | – | 993K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −71.4M | –% | -10.70 | – |
| FY2024 | – | – | −74.1M | –% | -11.39 | −55.7M |
| FY2023 | – | – | −156M | –% | -24.00 | −103M |
| FY2022 | – | – | −223M | –% | -34.46 | −265M |
| FY2021 | 0.00 | -100.0% | −157M | –% | -1.48 | −180M |
| FY2020 | 138K | – | −37.7M | -27,346.4% | -2.36 | −80.4M |